Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...

Metabolic-associated steatohepatitis (MASH) can cause liver damage, which can be stopped or reversed if it’s caught early. Learn more about the treatments that may help.

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, ...

The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg ...

Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...

The European Association for the Study of Obesity (EASO) has called for GLP-1 agonists from Novo Nordisk and Eli Lilly to be ...